Mucus Relief Extended Release Tablet, Extended Release
Product Images NDC 0536-1163

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Mucus Relief Extended Release (NDC 0536-1163). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rugby Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Guaifenesin 600 mg (Mucus Relief 600 mg Extended Release Caplets 1)

This is a drug information sheet for extended-release tablets containing 610 g guaifenesin as an expectorant. It is used to help loosen phlegm and make coughs more productive. The product should not be given to children under 12 years of age, and pregnant or breastfeeding women should consult a healthcare professional before use. The directions for use include taking one to two tablets every 12 hours for children aged 12 years and above, without regard to food. The product should not be crushed, chewed, or broken. In case of an overdose, contact Poison Control immediately. The inactive ingredients include carbomer, colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, povidone, and sodium starch glycolate. This product is manufactured by Rugby Laboratories and distributed by Bookstone LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.